Tara Elisabeth Seery

Picture of Tara Elisabeth Seery
HS Assistant Clinical Professor, Division of Hematology/ Oncology
B.S., Vanderbilt University, 1996
M.D., University College Dublin, 2001
Phone: (714) 456-5153
Email: tseery@uci.edu
University of California, Irvine
Bldg. 56 Rm. 240 Zot: 4061
Irvine, CA 92697
Research Interests
Pancreatic Cancer, Bile duct cancers, liver cancer, colorectal cancer, gastroesophageal cancers
Publications
Seery, T.E., Ziogas, A., Lin, B., Pan, CG, Stamos, M., Zell, J. Mortality Risk After Preoperative versus Postoperative Chemotherapy and Radiotherapy in Lymph Node Postive Rectal Cancer. Journal of Gastrointestinal Surgery, 2013 Feb; 17, 374-381
Villano, J.E., Seery, T.E., Bressler, L.R. Temozolomide in malignant gliomas: current use and future targets. Cancer Chemotherapy and Pharmacology, 2009 Mar; 64 (4), 647-655
Seery, T.E., Sycheva T., and Oo ,T. The Prevalence of Second Malignancies and Autoimmune Diseases in Patients with Lymphoproliferative Disorders. Blood, November 2006; 108, Abstract 4608.

Seery, T., Blanchard E. Bilateral DCIS in a Male Patient. Community Oncology 2007

Mohamed T., Sycheva T., Seery T., Schneider D., et al. In apparent Von Willebrand’s Disease as the Underlying Cause of Menorrhagia Attributed to Uterine Fibroids. Transfusion 2007.
Professional Societies
American Society of Clinical Oncology
American Society of Hematology
Graduate Programs
Hematology and Oncology (IM)
Internal Medicine
Last updated
10/04/2013